ZA989450B - Novel use of compounds for anti-pruritic activity - Google Patents

Novel use of compounds for anti-pruritic activity

Info

Publication number: ZA989450B
Authority: ZA; South Africa
Prior art keywords: compounds; novel use; pruritic activity; pruritic; activity
Prior art date: 1997-10-17

Application number

ZA989450A

Inventor

Don E Griswold

Siegfried B Christensen Iv

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-17

Filing date

1998-10-16

Publication date

1999-04-19

1998-10-16 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

1999-04-19 Publication of ZA989450B publication Critical patent/ZA989450B/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

ZA989450A 1997-10-17 1998-10-16 Novel use of compounds for anti-pruritic activity ZA989450B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US6374697P	1997-10-17	1997-10-17

Publications (1)

Publication Number	Publication Date
ZA989450B true ZA989450B (en)	1999-04-19

Family

ID=22051225

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA989450A ZA989450B (en)	1997-10-17	1998-10-16	Novel use of compounds for anti-pruritic activity

Country Status (18)

Country	Link
EP (1)	EP1030666A4 (en)
JP (1)	JP2001520196A (en)
KR (1)	KR20010031149A (en)
CN (1)	CN1306426A (en)
AR (1)	AR015966A1 (en)
AU (1)	AU740875B2 (en)
BR (1)	BR9814080A (en)
CA (1)	CA2306985A1 (en)
CO (1)	CO4810374A1 (en)
CZ (1)	CZ20001376A3 (en)
HU (1)	HUP0003792A3 (en)
IL (1)	IL135581A0 (en)
NO (1)	NO20001847L (en)
NZ (1)	NZ503551A (en)
PL (1)	PL341062A1 (en)
TR (1)	TR200001040T2 (en)
WO (1)	WO1999020280A1 (en)
ZA (1)	ZA989450B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7250518B2 (en)	2001-01-31	2007-07-31	Pfizer Inc.	Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
NZ526531A (en)	2001-01-31	2005-02-25	Pfizer Prod Inc	Ether derivatives useful as inhibitors of phosphodiesterase type IV (PDE4) isozymes
HUP0401305A2 (en)	2001-01-31	2004-10-28	Pfizer Products Inc.	Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives as inhibitors of pde4 isozymes and pharmaceutical compositions containing them
EE200300360A (en)	2001-01-31	2003-12-15	Pfizer Products Inc.	Biaryl derivatives of nicotinamide used as inhibitors of PDE4 isozymes
US20030175314A1 (en) *	2001-11-19	2003-09-18	Didriksen Erik Johannes	Pharmaceutical composition for dermal application
US20060258703A1 (en) *	2003-07-17	2006-11-16	Ono Pharmaceutical Co., Ltd.	Remedy for pruritus comprising piperidine derivative as the active ingredient
JP2005187458A (en) *	2003-12-04	2005-07-14	Santen Pharmaceut Co Ltd	Itchiness-treating agent consisting of cilomilast or its salt as active ingredient
WO2005053672A1 (en) *	2003-12-04	2005-06-16	Santen Pharmaceutical Co., Ltd.	Remedy for pruritus comprising cilomilast or salt thereof as the active ingredient
HRP20130406T1 (en) *	2004-02-14	2013-06-30	Glaxosmithkline Intellectual Property Development Limited	Medicaments with hm74a receptor activity
JP2008137892A (en) *	2005-03-04	2008-06-19	Eisai Co Ltd	Antipruritic agent
MX2008001931A (en)	2005-08-10	2008-03-24	Smithkline Beecham Corp	Xanthine derivatives as selective hm74a agonists.
TWI404709B (en) *	2006-02-21	2013-08-11	Eisai R&D Man Co Ltd	4-(3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives
MX2008010774A (en) *	2006-02-21	2008-09-01	Eisai R&D Man Co Ltd	4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative.
EP2123641A4 (en)	2007-02-16	2011-06-22	Eisai R&D Man Co Ltd	Crystal, amorphous form and salt of methyl n-ý3-(6,7-dimethoxy- 2-methylaminoquinazolin-4-yl)phenyl¨terephthalamic acid
CN101687820B (en)	2007-08-17	2012-07-25	卫材R&D管理有限公司	The manufacture method of quinazoline derivative
US8513269B2 (en)	2007-08-17	2013-08-20	Eisai R&D Management Co., Ltd.	Preparation for external use
WO2013002196A1 (en)	2011-06-28	2013-01-03	田辺三菱製薬株式会社	Novel pharmaceutical composition
AU2016212625B2 (en)	2015-01-30	2020-03-26	Shanton Pharma Pte. Ltd.	Prevention or treatment of uric acid or gout disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5409934A (en) *	1990-12-21	1995-04-25	Smith; David G.	Xanthine derivatives
EP0889886B1 (en) *	1996-03-26	2002-09-18	ALTANA Pharma AG	Novel phenanthridines substituted in the 6 position
EP0912568B1 (en) *	1996-05-15	2002-11-20	ALTANA Pharma AG	imidazopyridines
ES2206909T3 (en) *	1997-03-07	2004-05-16	Altana Pharma Ag	DERIVATIVES OF TETRAZOL.
JP2002504091A (en) *	1997-03-18	2002-02-05	ベーアーエスエフアクツィエンゲゼルシャフト	Methods and compositions for modulating responsiveness to corticosteroids
JP2002502403A (en) *	1997-06-03	2002-01-22	ビイクグルデンロンベルクヒエーミツシエフアブリークゲゼルシヤフトミツトベシユレンクテルハフツング	Benzonaphthyridine

1998
- 1998-10-15 AR ARP980105131A patent/AR015966A1/en not_active Application Discontinuation
- 1998-10-16 IL IL13558198A patent/IL135581A0/en unknown
- 1998-10-16 NZ NZ503551A patent/NZ503551A/en unknown
- 1998-10-16 KR KR1020007004053A patent/KR20010031149A/en not_active Withdrawn
- 1998-10-16 AU AU10938/99A patent/AU740875B2/en not_active Ceased
- 1998-10-16 HU HU0003792A patent/HUP0003792A3/en unknown
- 1998-10-16 EP EP98953608A patent/EP1030666A4/en not_active Withdrawn
- 1998-10-16 CO CO98060225A patent/CO4810374A1/en unknown
- 1998-10-16 WO PCT/US1998/021886 patent/WO1999020280A1/en not_active Application Discontinuation
- 1998-10-16 TR TR2000/01040T patent/TR200001040T2/en unknown
- 1998-10-16 CA CA002306985A patent/CA2306985A1/en not_active Abandoned
- 1998-10-16 JP JP2000516677A patent/JP2001520196A/en not_active Withdrawn
- 1998-10-16 BR BR9814080-9A patent/BR9814080A/en not_active IP Right Cessation
- 1998-10-16 PL PL98341062A patent/PL341062A1/en unknown
- 1998-10-16 CN CN98810066A patent/CN1306426A/en active Pending
- 1998-10-16 CZ CZ20001376A patent/CZ20001376A3/en unknown
- 1998-10-16 ZA ZA989450A patent/ZA989450B/en unknown
2000
- 2000-04-10 NO NO20001847A patent/NO20001847L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
KR20010031149A (en)	2001-04-16
CZ20001376A3 (en)	2002-06-12
WO1999020280A1 (en)	1999-04-29
JP2001520196A (en)	2001-10-30
NO20001847D0 (en)	2000-04-10
EP1030666A4 (en)	2002-10-16
HUP0003792A2 (en)	2001-10-28
AU1093899A (en)	1999-05-10
NZ503551A (en)	2002-05-31
BR9814080A (en)	2000-09-26
EP1030666A1 (en)	2000-08-30
CO4810374A1 (en)	1999-06-30
HUP0003792A3 (en)	2001-12-28
CA2306985A1 (en)	1999-04-29
PL341062A1 (en)	2001-03-26
AU740875B2 (en)	2001-11-15
IL135581A0 (en)	2001-05-20
NO20001847L (en)	2000-04-10
AR015966A1 (en)	2001-05-30
CN1306426A (en)	2001-08-01
TR200001040T2 (en)	2001-01-22

Publication	Publication Date	Title
IL134086A0 (en)	2001-04-30	Novel spiroazabicyclic heterocyclic compounds
HUP0003792A3 (en)	2001-12-28	Novel use of compounds for anti-pruritic activity
EG24041A (en)	2008-04-03	New heterocyclic compounds
EG24412A (en)	2009-05-25	Novel compounds
EG24177A (en)	2008-09-28	Novel compounds
PL340400A1 (en)	2001-01-29	2-phenyl-substituted imidazotriazinones as inhibitors of phosphodiesterase
IL132170A0 (en)	2001-03-19	Novel heterocyclic compounds
PL338791A1 (en)	2000-11-20	Compounds exhibiting neuronic activity
IL125840A0 (en)	1999-04-11	Production of bromine compounds
IL113248A0 (en)	1995-07-31	Use of alpha - 1c specific compounds
PL327732A1 (en)	1998-12-21	Compounds of therapeutic activity
GB9701674D0 (en)	1997-03-19	Use of organic compounds
ZA981920B (en)	1998-09-07	Novel heterocyclic compounds
HU9800373D0 (en)	1998-04-28	Steroide compounds of anticeptive and antiosteoporosive activity
PL327538A1 (en)	1998-12-21	Novel compounds of analgesic activity
PL339673A1 (en)	2001-01-02	Novel compounds suitable for use as neuroprotective agents
ZA985448B (en)	1999-01-19	Novel heterocyclic compounds
HU9700442D0 (en)	1997-04-28	Compounds of pharmaceutical activity
ZA983800B (en)	1998-11-06	Novel heterocyclic compounds
AUPP059897A0 (en)	1998-01-08	New use of bicozamycin
GB9703492D0 (en)	1997-04-09	Novel compounds
GB9722026D0 (en)	1997-12-17	Use of compounds
SI1121108T1 (en)	2003-10-31	Novel therapeutic use of compounds with beta-3-agonist activity
ZA985449B (en)	1999-01-19	Novel heterocyclic compounds
GB9810855D0 (en)	1998-07-22	Use of compounds